Samorita Hospital Limited — Company profile

Hospitals · Bangladesh

Last price 84.7 BDT (At close: Oct 29, 2026) · Market cap 1.85B

Latest research: Samorita Hospital financial analysis: 3.4% net margin, land is 74% of assets, qualified audit (Oct 2026) · Samorita Hospital: revenue BDT 401.4m in FY2025, land BDT 884.3m on the balance sheet, FY2026 EPS BDT 1.12

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

Samorita Hospital Limited provides general hospital services in Bangladesh. The company operates through Medical Services, Diagnostic, Pharmacy, and Other segments. It provides clinical services, including internal medicine, gynecology and obstetrics, pediatrics, neonatology, cardiology, respiratory, nephrology, urology, neurology/neurosurgery, and immunization; general, pediatric, cardiothoracic, orthopedic, plastic, and laparoscopic surgery; dental department, gastroenterology, ophthalmology, ENT, oncology, psychiatry, tropical and physical medicine; and outdoor medical and 24 hours ambulance services. The company also provides diagnostic services comprising CT scan, x-ray, EEG, ECG and ETT, color doppler, echocardiography, ultrasonography, video endoscopy/colonoscopy, pathology, and BMD services. In addition, it operates intensive care, stroke, coronary care, neonatal intensive care, haemodialysis, and high care units; diabetes, hypertension, endocrine, and medical check-up center; operations theaters; labour room; and observation ward. Samorita Hospital Limited was founded in 1984 and is based in Dhaka, Bangladesh.

Details

Key executives

Contact